Hubei Goto Biopharm Co.,Ltd.
SZSE:300966.SZ
21.06 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 536.596 | 566.399 | 604.571 | 590.885 | 468.117 | 464.802 | 437.302 | 333.692 |
| Cost of Revenue
| 431.033 | 450.291 | 466.352 | 434.975 | 361.494 | 333.114 | 306.327 | 231.702 |
| Gross Profit
| 105.562 | 116.108 | 138.22 | 155.911 | 106.624 | 131.688 | 130.975 | 101.99 |
| Gross Profit Ratio
| 0.197 | 0.205 | 0.229 | 0.264 | 0.228 | 0.283 | 0.3 | 0.306 |
| Reseach & Development Expenses
| 51.083 | 38.099 | 45.147 | 37.123 | 21.604 | 26.056 | 27.104 | 23.464 |
| General & Administrative Expenses
| 25.633 | 16.76 | 15.075 | 18.53 | -6.118 | -40.602 | -29.605 | -14.629 |
| Selling & Marketing Expenses
| 3.934 | 4.177 | 4.907 | 5.471 | 3.454 | 4.467 | 4.273 | 3.341 |
| SG&A
| 29.567 | 20.937 | 19.982 | 24.001 | -2.664 | -36.135 | -25.331 | -11.288 |
| Other Expenses
| 67.334 | 3.874 | -0.39 | 23.405 | 10.065 | 36.658 | 31.961 | 19.093 |
| Operating Expenses
| 147.984 | 96.579 | 85.29 | 83.473 | 40.705 | 38.843 | 44.293 | 39.988 |
| Operating Income
| -42.422 | 19.53 | 38.904 | 62.712 | 57.3 | 79.695 | 78.333 | 55.209 |
| Operating Income Ratio
| -0.079 | 0.034 | 0.064 | 0.106 | 0.122 | 0.171 | 0.179 | 0.165 |
| Total Other Income Expenses Net
| -3.113 | -0.414 | -0.39 | 23.405 | 2.942 | 3.117 | 2.053 | 0.432 |
| Income Before Tax
| -45.535 | 19.116 | 38.514 | 86.117 | 60.242 | 82.811 | 80.386 | 55.642 |
| Income Before Tax Ratio
| -0.085 | 0.034 | 0.064 | 0.146 | 0.129 | 0.178 | 0.184 | 0.167 |
| Income Tax Expense
| -13.879 | -2.174 | -0.982 | 8.051 | 7.047 | 9.815 | 9.708 | 8.203 |
| Net Income
| -27.591 | 23.005 | 40.205 | 78.331 | 53.289 | 72.996 | 70.678 | 47.439 |
| Net Income Ratio
| -0.051 | 0.041 | 0.067 | 0.133 | 0.114 | 0.157 | 0.162 | 0.142 |
| EPS
| -0.24 | 0.2 | 0.35 | 0.68 | 0.46 | 0.63 | 0.84 | 1.03 |
| EPS Diluted
| -0.24 | 0.2 | 0.35 | 0.68 | 0.46 | 0.63 | 0.84 | 1.03 |
| EBITDA
| 21.228 | 60.505 | 79.117 | 116.39 | 88.176 | 104.767 | 100.328 | 69.111 |
| EBITDA Ratio
| 0.04 | 0.107 | 0.131 | 0.197 | 0.188 | 0.225 | 0.229 | 0.207 |